Showing 1211-1220 of 2167 results for "".
Treatment Strategies for Retinal Vascular Diseases
https://modernod.com/topics/retina/treatment-strategies-for-retinal-vascular-diseases/38891/A review of the protocols and therapies for managing these complex conditions.What’s Out and What’s in for Treating Corneal Fibrosis
https://modernod.com/topics/corneaanterior-segment/whats-out-and-whats-in-for-treating-corneal-fibrosis/38869/Emerging regenerative therapies are expanding.Myth-Busting the 20/20/20 Rule
https://modernod.com/topics/myopia/myth-busting-the-202020-rule/38651/Many regularly recommend this guideline to patients, but what do the data actually say about it?Optimizing vision in CXL Patients
https://modernod.com/mod-issues/2020-oct/optimizing-vision-in-cxl-patients/39112/Two optometrists unpack the refractive toolbox.Neuroprotection and Glaucoma: Old Challenges, New Solutions
https://modernod.com/mod-issues/2020-apr/neuroprotection-and-glaucoma-old-challenges-new-solutions/39101/New drug targets and approaches to designing clinical trials hold promise for the development of neuroprotective therapies for glaucoma.DREAM Interpretations Abound Following Surprising Dry Eye Study Findings
https://modernod.com/topics/ocular-surface/dream-interpretations-abound-following-surprising-dry-eye-study-findings/39173/Control and placebo groups in DREAM both achieved similar improvements in OSDI scores; study authors concluded that omega-3 supplements were no better than the refined olive oil placebo.Lessons in Value
https://modernod.com/mod-issues/julyaugust-2025-supplement/lessons-in-value/39002/What my experiences in patient care have taught me.Glaucoma Pipeline
https://glaucomatoday.com/resource/glaucoma-pipeline-2022Left Behind
https://modernod.com/topics/cataractrefractive-surgery/left-behind/39838/A rare complication of cataract surgery can cause a range of visual problems.Visionary Breakthroughs
https://modernod.com/articles/visionary-breakthroughs/visionary-breakthroughs-1/39818/A Spotlight on Innovations in Eye Care